Correlation Between Bellevue Group and BB Biotech

Can any of the company-specific risk be diversified away by investing in both Bellevue Group and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bellevue Group and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bellevue Group AG and BB Biotech AG, you can compare the effects of market volatilities on Bellevue Group and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bellevue Group with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bellevue Group and BB Biotech.

Diversification Opportunities for Bellevue Group and BB Biotech

-0.08

Correlation Coefficient

Bellevue Group  BB Biotech

Good diversification

The 3 months correlation between Bellevue and BION is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Bellevue Group AG and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and Bellevue Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bellevue Group AG are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of Bellevue Group i.e., Bellevue Group and BB Biotech go up and down completely randomly.

Pair Corralation between Bellevue Group and BB Biotech

Assuming the 90 days trading horizon Bellevue Group AG is expected to under-perform the BB Biotech. In addition to that, Bellevue Group is 1.11 times more volatile than BB Biotech AG. It trades about -0.31 of its total potential returns per unit of risk. BB Biotech AG is currently generating about -0.01 per unit of volatility. If you would invest  3,795  in BB Biotech AG on September 4, 2024 and sell it today you would lose (40.00) from holding BB Biotech AG or give up 1.05% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Bellevue Group AG  vs.  BB Biotech AG

Bellevue Group AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bellevue Group AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

BB Biotech AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Bellevue Group and BB Biotech

The main advantage of trading using opposite Bellevue Group and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bellevue Group position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.

The idea behind Bellevue Group AG and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.